• What if you could put a lab directly into a human body? What if you could design drugs that target specific diseases with minimal side effects? What if you could create a miniature lab that replicated a human organ? These fascinating “what ifs” are fast becoming reality in the rapidly changing industry of pharmaceuticals and life sciences.

  • It is a transformation that is occuring against a backdrop of increased competition from generic rivals, funding challenges for small market targeted “smart” drugs and the decline of “rainmaker” blockbuster drugs.

  • The convergence of the life and physical sciences with engineering, computer science and biotechnology is attracting a new breed of worker to the industry and dramatically changing the type and process of work.

  • These changes demand an urgent rethink of traditional workplace and real estate solutions – one that CBRE Research foresees will drive the creation of new kinds of workspaces that bring together diverse fields and expertise as pharmaceuticals companies partner with start-ups, universities and even their competitors.